SageView Advisory Group’s AngioDynamics ANGO Stock Holding History

SageView Advisory Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-56	Closed	-$720	–	665
2025 Q4	$720	Buy	+56	New	+$691	﹤0.01%	2406

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $118M AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $295M AUM 19.08% 1-Year Est. Return

SageView Advisory Group's ANGO Position: Q1 2026 in Review

SageView Advisory Group sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 56 shares — an estimated $720 sold.

SageView Advisory Group first reported a position in ANGO in Q4 2025 and held it in 1 quarter. The position peaked at $720 in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

SageView Advisory Group reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 56 AngioDynamics shares in Q1 2026, an estimated $720.
SageView Advisory Group first reported a position in AngioDynamics in Q4 2025 and held it in 1 quarter.
SageView Advisory Group's AngioDynamics position peaked at $720 in Q4 2025.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.